Home / Import refusals / 1FX-0874542-3/10002/1

FDA Import Refusal 1FX-0874542-3/10002/1 — Ziska Pharmaceuticals Ltd.

Ziska Pharmaceuticals Ltd. — FEI 3033302267

The FDA refused shipment 1FX-0874542-3/10002/1 from Ziska Pharmaceuticals Ltd. (India) on May 4, 2026. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 3 other import refusals on record.

Refusal Details

Date
May 4, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
61PCL74 TIRZEPATIDE (ANTI-DIABETIC)
Charges
75

Other import refusals

  • AEK-0388727-9/50002/1 (Thu May 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-8924302-9/10003/1 (Fri Dec 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-6313515-8/11/1 (Mon Apr 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources